Clinical and survival characteristics of primary and secondary gliosarcoma patients.

Amer, Ahmad; Khose, Swapnil; Alhasan, Hamza; Pokhylevych, Halyna; Fuller, Greg; Chasen, Noah; de Groot, John; Johnson, Jason M

Amer, Ahmad; Khose, Swapnil; Alhasan, Hamza; Pokhylevych, Halyna; Fuller, Greg; Chasen, Noah; de Groot, John; Johnson, Jason M.

Affiliation

Amer A; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Khose S; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Alhasan H; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokhylevych H; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller G; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chasen N; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
de Groot J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Johnson JM; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: JJohnson12@mdanderson.org.

Clin Neurol Neurosurg ; 214: 107146, 2022 03.

Article de En | MEDLINE | ID: mdl-35101778

Sujet(s)
Mots clés

Gliosarcoma; Primary gliosarcoma; Secondary gliosarcoma; TP53 mutation

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cerveau / Gliosarcome / Glioblastome Type d'étude: Observational_studies / Prognostic_studies Limites: Humans Langue: En Journal: Clin Neurol Neurosurg Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google